Assoc Prof of Med, GI with IBD focus @MayoClinic 🐊 | via @AUB_Lebanon @PittGIM @PittGILiverNutr | Chair of @AmerGastroAssn CPUC | ❤️research🧐🔬 to 📈👫Outcome

Florida, USA
Cheers to another successful AGA Leadership Summit! 👏🏼👏🏼👏🏼 Thank you, AGA leaders, for your ideas and leadership to grow the specialty! @VictorChedidMD @CulpepperJoan @JHashashMD @AndyChanMD @Jarshah4 @SultanShazi @drkylestaller @docbinujohn @priyanka_kanth
6
22
1,777
Thank you to the @AmerGastroAssn for this amazing opportunity, trust and support. @drkylestaller @IBDimmunology @SultanShazi @BCryer @alisonkimphd @AndyChanMD
Our clinical practice updates all-star team! 🤩 Thank you, @JHashashMD, for your work leading this committee!
1
43
2,068
AGA leaders are 🔐 in at Leadership Summit! We had a great first day and now we’re ready for more productive meetings and conversations! @BCryer @biancaislam @IssakaMD @JHashashMD @P_DeepakIBDMD
7
19
1,431
Jana G Hashash, MD, MSc retweeted
⭐ Up to one-third of patients with #IBD in remission have IBS-like symptoms. A new Rome Foundation–IOIBD consensus defines this phenotype and outlines diagnostic and treatment strategies: ow.ly/KcFh50ZHkfv
2
37
71
22,047
🔬📚 Revisión “state of the art” en enfermedad inflamatoria intestinal (EII) (BMJ, diciembre 2025) Un repaso actualizado y práctico sobre los aspectos clave de la EII: 1️⃣ Fisiopatología y nuevas dianas terapéuticas 2️⃣ Manifestaciones extraintestinales 3️⃣ Manejo de la colitis ulcerosa aguda grave 4️⃣ Enfermedad de Crohn postquirúrgica Imprescindible para estar al día en el abordaje integral de la EII. bmj.com/content/391/bmj-2025…
3
64
187
6,703
Jana G Hashash, MD, MSc retweeted
It was great to see how well the #IBD group at @MayoClinicFLGIH is doing and also great to see a thriving city-wide gut club! Thanks @ibdgijami for hosting! (And the golf cart tour @JHashashMD)
It was an honor to have colleague and mentor @EdwardLoftus2 visit our beautiful @MayoClinicFLGIH campus for the first time! as #IBD visiting professor and @BGFoundation904 Key Note Speaker for Anniversary Gut Club updating us on advances in #IBD
1
2
45
4,860
Jana G Hashash, MD, MSc retweeted
Hospitalized patients with #IBD from @AmerGastroAssn 1-IBD Workup 2-Endoscopy: Staging + CMV rule out 3-Progression: IV steroid (for uncontrolled) + Daily CRP 4-Assessment: Medical/Surgical rescue (for unresponsive) or Transition to PO (for responsive) gastrojournal.org/article/S0…
1
5
19
1,435
Stem Cell Transplants for Crohn’s disease @MayoClinic Incredibly thankful for our patients for their trust - below you can listen to Amy’s story! piped.video/SBB0rJ_zsxQ #ErnestoAyala @MadihaIqbal13 @MKD_BMT @ibdgijami @AmerGastroAssn @AmCollegeGastro @CrohnsColitisFn
After years of living with Crohn's disease and trying treatments that didn't work, Amy Marshak felt she was running out of options. The chronic illness affected her career, her energy and the everyday family moments she cherished most. At Mayo Clinic, she found a new treatment approach and renewed hope for the future. Learn more about her treatment: mayocl.in/4h0zIMm @JHashashMD | @MayoClinicGIHep | @MayoClinicFLGIH
1
5
37
4,505
Jana G Hashash, MD, MSc retweeted
A Joint @RomeFoundation and @IOIBD1 Consensus provides standardized terminology, evaluation strategies, and treatment recommendations for #IBD with #IBS-like symptoms 🔖 in @AGA_Gastro 👉 doi.org/10.1053/j.gastro.202…
7
10
1,505
We’re your GI home throughout fellowship and beyond! Unlock more resources, and education to support your GI career by joining AGA for free as a first-year trainee. Apply here: gastro.org/membership/benefi….
5
22
1,035
Jana G Hashash, MD, MSc retweeted
📣 #CC360 has ⬆️ its 2025 impact factor to 3🏆 🥳Congrats authors, AEs & @CrohnsColitisFn for advancing high quality #MedEd & #IBD care 💻 Submit your manuscript for an impactful 🌎 reach 📲If interested to be an AE (adult & peds IBD, surgery, GastroPsych, PharmD, GastroRD)
2
11
46
5,183
If you missed my debate with #DrSiegel on using anti-TNF vs anti-IL23 for #CD in pts with #cancer @CrohnsColitisFn, do not worry as @gastroendonews highlights 🔑 points below👇 👉 reference: AGA CPU which I coauthored with @DrJordanAxelrad @AGA_CGH pubmed.ncbi.nlm.nih.gov/3875…
Active Crohn’s disease + cancer treatment = complex decisions. At #CCC2026, experts debated anti-TNF vs IL-23p19 therapy + what matters most when balancing disease control, safety, and patient priorities: gastroendonews.com/a/oTsBAA/… #IBD #CrohnsDisease
2
10
32
4,234
Jana G Hashash, MD, MSc retweeted
Of course !!! You are an amazing teacher and educator !! Congratulations @JHashashMD thank you for all the work you do to shape the next gen of GI stars !
1
3
487
Jana G Hashash, MD, MSc retweeted
You’re my Top Teacher too 😍📚
1
2
601
Incredibly humbled to receive one of the 2026 🏆 Top Teacher Awards🏅from the Internal Medicine Residents 👩‍⚕️👨‍⚕️🩺 @mayofl_imres @MayoGIMFL
25
10
144
8,177
Patients with #IBD involving the colon face an 8️⃣x greater risk of #CDiff infection than the general population. Read more: ow.ly/63bO50ZabPW
1
10
23
1,910
MUST READ📖 Joint @RomeFoundation & @IOIBD1 RAND/UCLA Recommendations for #Evaluation & #Managmt of #IBD with #IBS-like Symptoms @AGA_Gastro pubmed.ncbi.nlm.nih.gov/4206… 📝Nomenclature: IBD with IBS-like symptoms Evaluation🩺 🧫 Therapies 🥗Diet 💊Drugs💉 🧠Brain gut behavioral tx
39
61
5,584
Jana G Hashash, MD, MSc retweeted
🚨 New Publication! 🚨 Excited to share our new article in @JCGjournal: “Comparison of Ustekinumab and Vedolizumab Effectiveness in Perianal Crohn’s Disease” Our findings suggest a potential effectiveness benefit of UST over VZD in patients with PCD, with lower rates of fistula-related surgery and antibiotic use. @JHashashMD @FarrayeIBD @OmarMTag @jensemineriomd 👉 Read the article here: doi.org/10.1097/mcg.00000000…
2
5
45
7,335
Jana G Hashash, MD, MSc retweeted
Congratulations @EileenMOReilly @MSKCancerCenter @MSK_DeptOfMed Brian Wolpin Ziv Wainberg and all colleagues on a long awaited and badly needed game changer in #pancreascancer
4
37
235
16,584
Jana G Hashash, MD, MSc retweeted
23
56
3,881